Probiotics, the gut and psoriasis: seven trials, one pooled result, and the strain nobody can name yet

The gut is involved; how is not settled

The idea that the gut has something to do with a skin disease used to sound like wellness talk. It no longer does. A 2025 systematic review of studies that sequenced the gut microbiota of people with psoriasis found distinct patterns compared with healthy controls, and noted that interventions which change the microbiota, probiotic supplementation in particular, produced measurable improvements in severity scores and inflammatory markers. It also found that the specific microbial signatures were inconsistent across studies, and concluded that the field needs standardised methods and larger longitudinal studies before anyone can say what causes what ^[5].

Hold both halves of that. The difference is real enough to be found repeatedly. What the difference consists of, and whether it drives the psoriasis or follows from it, or from the diet and the medicines that go with it, is not established. A microbiome that looks different is a lead, not a mechanism, and it is certainly not a shopping list.

Sources for this section: [5] Characterization of the Gut Microbiota in Patients with Psoriasis: A Systematic Review

Seven trials, pooled: a real signal with a wide margin

The direct test is a randomised trial of probiotics against placebo in people with psoriasis, and seven of them qualified for a 2024 meta-analysis. Pooled, the probiotic groups' severity index fell by a mean difference of -3.09 relative to placebo, with a confidence interval from -5.04 to -0.74, and C-reactive protein fell as well. The share of people reaching a 75% improvement was higher with probiotics, 33.57% against 23.61%, but the confidence interval on that crossed one. Quality of life did not differ significantly, and neither did adverse events ^[3]. The authors' conclusion: oral probiotics can improve psoriasis, and large randomised controlled trials are needed to support that conclusion ^[3].

A 2026 umbrella review, a review of the reviews, reached the same place from above: probiotics, particularly multistrain formulations, show potential as a safe and effective adjuvant for reducing severity and improving quality of life, and further trials are needed to identify the most effective strains and the optimal duration ^[4]. The 2025 network meta-analysis of supplements in psoriasis included probiotics among its twenty-one trials and found no supplement dominated across outcomes, with low-to-moderate certainty overall ^[6].

So the signal is there and it points the right way. What the reviews say in their last sentences is the part that matters for a purchase: the most effective strains and the optimal duration are still to be identified ^[4]. A pooled effect across trials whose products the reviewers cannot yet rank is a pooled effect that no single product on a shelf can claim.

Sources for this section: [3] The efficacy and safety of probiotics in the adjuvant treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials · [4] The Effectiveness of Probiotics in Psoriasis: An Umbrella Review · [6] Effectiveness and safety of dietary supplements in the adjunctive treatment of psoriasis: a systematic review and network meta-analysis

Adjuvant is the word to notice

The meta-analysis is titled as a study of adjuvant treatment and the umbrella review frames probiotics as a possible adjuvant ^[4]: an addition to treatment, which is the setting in which the effect was measured. Nothing in the evidence cited here supports a probiotic instead of a prescription, and a pooled mean difference of -3.09 is a shift on the index measured alongside treatment, not a treatment.

That framing also answers the leaky-gut version of the story, which has run ahead of the science. The microbiome review found association and inconsistency; it did not find a permeable gut causing plaques, and it said so ^[5]. A person can take the probiotic evidence seriously without taking on the mechanism that has been bolted to it online.

On harm, the trials report what they measured and no more. The seven-trial meta-analysis found no significant difference in adverse events between probiotic and placebo groups, on a risk ratio whose confidence interval ran from 0.37 to 1.25 ^[3], and the 2025 network meta-analysis across all supplements found adverse events comparable, with a risk ratio of 1.02 ^[6]. That is what seven trials can say; it is not a safety verdict on a product none of them tested. The cost of taking one on the current evidence is money and the risk of expecting more from it than a modest add-on effect, and of letting that expectation displace the treatment it was measured on top of.

Sources for this section: [3] The efficacy and safety of probiotics in the adjuvant treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials · [5] Characterization of the Gut Microbiota in Patients with Psoriasis: A Systematic Review · [6] Effectiveness and safety of dietary supplements in the adjunctive treatment of psoriasis: a systematic review and network meta-analysis

What the guidance does with it

The 2025 systematic review of dietary recommendations for psoriasis lists probiotic and prebiotic intake among the things that may be associated with improved outcomes, in the same breath as fibre, omega-3 and the Mediterranean, gluten-free and calorie-restricted patterns, and states that high-quality evidence on diet and psoriasis is currently lacking ^[2]. That is the most positive a guidance document cited here gets. The National Psoriasis Foundation's dietary review makes its recommendations about weight and about gluten and files the rest under low-quality data ^[7], and the clinical-practice review of nutrition in psoriasis spends its recommendations on the Mediterranean diet, calorie restriction and gluten ^[10]; probiotics appear in neither set.

The honest position is that this is one of the more interesting supplement stories in psoriasis and it is still early. Whether to try one is a conversation with the dermatologist who is treating you, because the only setting in which the trials found an effect was alongside treatment, and the product on the shelf has not been matched to any of them.

Sources for this section: [2] Evidence-based dietary recommendations for patients with psoriasis: A systematic review

Where yoghurt fits

Fermented food is not a probiotic trial, and this page does not treat it as one. What yoghurt and cheese are is part of the eating pattern that has a randomised trial in psoriasis: the trial's protocol describes that pattern as including fermented dairy products in moderation ^[8]. And dairy is something the national survey measured people with psoriasis consuming less of than matched controls ^[9].

The eating pattern with a randomised trial behind it in psoriasis is the Mediterranean diet, which in sixteen weeks improved the severity index by a between-group difference of -3.4 ^[1], a change of the same order as the pooled probiotic effect, from food rather than a capsule. That pattern's protocol asked for legumes three times a week, whole grains over refined, and two or more servings of vegetables and three of fruit a day, with fermented dairy in moderation ^[8]. The free seven-day psoriasis week on this site is built on it. If the probiotic trials grow up into a recommendation, this page will say so; until then, the yoghurt is on the menu for its own sake.

One more thing worth separating. The probiotic trials tested capsules of organisms; the diet trial tested a pattern of food. The 2025 review of dietary recommendations lists fibre, prebiotic and probiotic intake side by side among the things that may be associated with better outcomes ^[2], and of those three, the plate is the one with a controlled result behind it. That is not a probiotic claim. It is the reason the plate, not the capsule, is where this page ends.

Sources for this section: [1] Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial